In the future, attempts should be made to verify the interaction among CEACAM1, MMP‐9, and NGAL, and to further illustrate the roles of CEACAM1 in the IS, ischemia–reperfusion injury and secondary infection in the patients and animal models. Here, LCN2 is linked to infection.